Skip to content

External beam radiation therapy versus stent insertion for dysphagia relief in esophageal cancer

External beam radiation therapy versus stent insertion for dysphagia relief in esophageal cancer: a multi-center randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25069
Enrollment
200
Registered
2018-03-20
Start date
2018-11-14
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer Dysphagia Palliative treatment External beam radiation therapy Stent insertion

Interventions

Patients will be randomized to either SEMS insertion (Niti-S S Esophageal Stent) or EBRT (5 fractions of 4 Gy each with opposing fields in anterior-posterior direction).

Sponsors

Erasmus Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Histologically proven esophageal cancer - Patients with metastases or inoperable patients - No curative treatment options available - Dysphagia grade of ≥ 2 - Age ≥ 18 years - Written informed consent

Exclusion criteria

Exclusion criteria: - Malignant extrinsic compression - Previous stent placement - Evidence of tumor within 2 cm of the upper esophageal sphincter - Presence of an esophagotracheal and/or -bronchial fistula

Design outcomes

Primary

MeasureTime frame
Primary outcome of this study will be “dysphagia response”, regarded as ≥1 grade reduction of the dysphagia symptom scale. Assessment of primary outcome will be conducted at 4-weeks follow-up.

Secondary

MeasureTime frame
Secondary objectives of this study include comparing: dysphagia response over time, NRS pain score, number of adverse events, quality of life, costs, dysphagia free survival and overall survival.

Contacts

Public ContactM.C.W. Spaander

Erasmus Medical Center Rotterdam

v.spaander@erasmusmc.nl+3117040704

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)